Key points are not available for this paper at this time.
Multiple myeloma (MM) is a highly heterogeneous disease with wide variations in patient outcome. [
Sachpekidis et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: